| Study population | |
| No. of patients | 57 |
| Age, mean ± SD | 35.4 ± 13.6 |
| Sex, male, no. (%) | 25 (43.9%) |
| Pregnant | 2 (3.5%) |
| Comorbidities | no. (%) |
| No comorbidity | 23 (30.4) |
| Malignant tumor/Neoplasm | 7 (12.3) |
| Asthma | 5 (8.8) |
| Psychiatric disorder | 4 (7.0) |
| Gynecologic disease | 3 (5.3) |
| Allergic rhinitis | 2 (3.5) |
| Atopic dermatitis | 2 (3.5) |
| Gastrointestinal disease | 2 (3.5) |
| Cardiovascular disease | 1 (1.8) |
| Traumatic subarachnoid hemorrhage | 1 (1.8) |
| Diabetes | 1 (1.8) |
| Dyslipidemia | 1 (1.8) |
| Herpes labialis | 1 (1.8) |
| Migraine | 1 (1.8) |
| Symptoms | no. (%) |
| Fever (>37.4 °C) | 15 (26.3) |
| Sore throat | 11 (19.3) |
| Acute onset olfactory/taste disorders | 10 (17.5) |
| Cough/sputum | 8 (14.0) |
| Headache | 7 (12.3) |
| Fatigue | 4 (7.0) |
| Nasal drip/congestion | 4 (7.0) |
| Joint pain | 1 (1.8) |
| Diarrhea | 1 (1.8) |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.